For patients with myeloma on an IMiD, how do you decide on the dosages of aspirin or anticoagulants in VTE prophylaxis ?

The phase III trial by Palumbo et al., PMID 21282540 is still the only prospective randomized trial of VTE prophylaxis in MM with "standard" thromboembolic risk patients eligible for IMiD treatment. In this study, administration of 40 mg enoxaparin was compared with fixed dose of 1.25 mg warfarin...